{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T05:51:57Z","timestamp":1697262717125},"reference-count":40,"publisher":"Elsevier BV","issue":"52","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.vaccine.2009.07.015","type":"journal-article","created":{"date-parts":[[2009,7,26]],"date-time":"2009-07-26T11:51:00Z","timestamp":1248609060000},"page":"7436-7441","source":"Crossref","is-referenced-by-count":11,"title":["Protection against anthrax and plague by a combined vaccine in mice and rabbits"],"prefix":"10.1016","volume":"27","author":[{"given":"Jun","family":"Ren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dayong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinlong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changming","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihua","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianmin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"December (12)","key":"10.1016\/j.vaccine.2009.07.015_bib1","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/nm1201-1271","article-title":"Bioterrorism: a clear and present danger","volume":"7","author":"Lane","year":"2001","journal-title":"Nature Medicine"},{"issue":"June (9)","key":"10.1016\/j.vaccine.2009.07.015_bib2","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.addr.2005.01.028","article-title":"Molecular basis for improved anthrax vaccines","volume":"57","author":"Brey","year":"2005","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10.1016\/j.vaccine.2009.07.015_bib3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.cellbio.19.111301.140655","article-title":"Anthrax toxin","volume":"19","author":"Collier","year":"2003","journal-title":"Annual Review of Cell and Developmental Biology"},{"issue":"November (6860)","key":"10.1016\/j.vaccine.2009.07.015_bib4","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/n35101999","article-title":"Identification of the cellular receptor for anthrax toxin","volume":"414","author":"Bradley","year":"2001","journal-title":"Nature"},{"issue":"April (9)","key":"10.1016\/j.vaccine.2009.07.015_bib5","doi-asserted-by":"crossref","first-page":"5170","DOI":"10.1073\/pnas.0431098100","article-title":"Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor","volume":"100","author":"Scobie","year":"2003","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2009.07.015_bib6","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1128\/CMR.10.1.35","article-title":"Yersinia pestis\u2014etiologic agent of plague","volume":"10","author":"Perry","year":"1997","journal-title":"Clinical Microbiology Reviews"},{"issue":"April (9568)","key":"10.1016\/j.vaccine.2009.07.015_bib7","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/S0140-6736(07)60566-2","article-title":"Plague","volume":"369","author":"Prentice","year":"2007","journal-title":"Lancet"},{"issue":"October (5748)","key":"10.1016\/j.vaccine.2009.07.015_bib8","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1126\/science.1118476","article-title":"The V-antigen of Yersinia forms a distinct structure at the tip of injectisome needles","volume":"310","author":"Mueller","year":"2005","journal-title":"Science"},{"issue":"October (8)","key":"10.1016\/j.vaccine.2009.07.015_bib9","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1084\/jem.20020908","article-title":"Yersinia V-antigen exploits toll-like receptor 2 and CD14 for interleukin 10-mediated immunosuppression","volume":"196","author":"Sing","year":"2002","journal-title":"The Journal of Experimental Medicine"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2009.07.015_bib10","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1128\/IAI.70.3.1453-1460.2002","article-title":"Role of fraction 1 antigen of Yersinia pestis in inhibition of phagocytosis","volume":"70","author":"Du","year":"2002","journal-title":"Infection and Immunity"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2009.07.015_bib11","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.1128\/IAI.64.11.4580-4585.1996","article-title":"Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis","volume":"64","author":"Anderson","year":"1996","journal-title":"Infection and Immunity"},{"issue":"November\u2013December (6)","key":"10.1016\/j.vaccine.2009.07.015_bib12","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3201\/eid0706.010604","article-title":"Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States","volume":"7","author":"Jernigan","year":"2001","journal-title":"Emerging Infectious Diseases"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2009.07.015_bib13","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1128\/IAI.73.6.3734-3739.2005","article-title":"Protein microarray for profiling antibody responses to Yersinia pestis live vaccine","volume":"73","author":"Li","year":"2005","journal-title":"Infection and immunity"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2009.07.015_bib14","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0264-410X(91)90237-Z","article-title":"Anthrax vaccines: past, present and future","volume":"9","author":"Turnbull","year":"1991","journal-title":"Vaccine"},{"issue":"November (16)","key":"10.1016\/j.vaccine.2009.07.015_bib15","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/0264-410X(95)00090-N","article-title":"A comparison of Plague vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murine model","volume":"13","author":"Russell","year":"1995","journal-title":"Vaccine"},{"issue":"July (11\u201312)","key":"10.1016\/j.vaccine.2009.07.015_bib16","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0264-410X(98)80112-6","article-title":"Comparative efficacy of experimental anthrax vaccine candidates against inhalation anthrax in rhesus macaques","volume":"16","author":"Ivins","year":"1998","journal-title":"Vaccine"},{"issue":"March (14)","key":"10.1016\/j.vaccine.2009.07.015_bib17","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1016\/j.vaccine.2005.12.028","article-title":"Duration of protection of rabbits after vaccination with Bacillus anthracis recombinant protective antigen vaccine","volume":"24","author":"Little","year":"2006","journal-title":"Vaccine"},{"issue":"May (8)","key":"10.1016\/j.vaccine.2009.07.015_bib18","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0264-410X(97)00268-5","article-title":"Protective efficacy of a recombinant protective antigen against Bacillus anthracis challenge and assessment of immunological markers","volume":"16","author":"McBride","year":"1998","journal-title":"Vaccine"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2009.07.015_bib19","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1128\/IAI.66.7.3447-3448.1998","article-title":"Study of immunization against anthrax with the purified recombinant protective antigen of Bacillus anthracis","volume":"66","author":"Singh","year":"1998","journal-title":"Infection and Immunity"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2009.07.015_bib20","doi-asserted-by":"crossref","first-page":"5978","DOI":"10.1128\/IAI.73.9.5978-5987.2005","article-title":"Immunogenicity of recombinant protective antigen and efficacy against aerosol challenge with anthrax","volume":"73","author":"Williamson","year":"2005","journal-title":"Infection and Immunity"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2009.07.015_bib21","doi-asserted-by":"crossref","first-page":"793","DOI":"10.4269\/ajtmh.1998.58.793","article-title":"Short- and long-term efficacy of single-dose subunit vaccines against Yersinia pestis in mice","volume":"58","author":"Anderson","year":"1998","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"issue":"September (25\u201326)","key":"10.1016\/j.vaccine.2009.07.015_bib22","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1016\/S0264-410X(03)00379-7","article-title":"Protective efficacy of a fully recombinant plague vaccine in the guinea pig","volume":"21","author":"Jones","year":"2003","journal-title":"Vaccine"},{"issue":"July (10)","key":"10.1016\/j.vaccine.2009.07.015_bib23","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0264-410X(96)00303-9","article-title":"A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunized animals against pneumonic plague","volume":"15","author":"Williamson","year":"1997","journal-title":"Vaccine"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2009.07.015_bib24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.micpath.2006.09.003","article-title":"Immunogenicity of the rF1+rV vaccine for plague with identification of potential immune correlates","volume":"42","author":"Williamson","year":"2007","journal-title":"Microbial Pathogenesis"},{"issue":"January (6)","key":"10.1016\/j.vaccine.2009.07.015_bib25","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.vaccine.2006.09.052","article-title":"Kinetics of the immune response to the (F1+V) vaccine in models of bubonic and pneumonic plague","volume":"25","author":"Williamson","year":"2007","journal-title":"Vaccine"},{"issue":"August (33\u201334)","key":"10.1016\/j.vaccine.2009.07.015_bib26","doi-asserted-by":"crossref","first-page":"5950","DOI":"10.1016\/j.vaccine.2006.05.044","article-title":"Immunogenicity and tolerance of ascending doses of a recombinant protective antigen (rPA102) anthrax vaccine: a randomized, double-blinded, controlled, multicenter trial","volume":"24","author":"Gorse","year":"2006","journal-title":"Vaccine"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2009.07.015_bib27","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1128\/IAI.73.6.3598-3608.2005","article-title":"Human immune response to a plague vaccine comprising recombinant F1 and V antigens","volume":"73","author":"Williamson","year":"2005","journal-title":"Infection and Immunity"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2009.07.015_bib28","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.pep.2007.10.011","article-title":"Design and preparation of non-tagged Yersinia pestis LcrV antigen in Escherichia coli and its immunogenicity in BALB\/c mice","volume":"57","author":"li","year":"2008","journal-title":"Protein Expression and Purification"},{"issue":"September (5)","key":"10.1016\/j.vaccine.2009.07.015_bib29","first-page":"652","article-title":"Expression, purification and characterization of the recombinant anthrax protective antigen","volume":"20","author":"Xu","year":"2004","journal-title":"Sheng Wu Gong Cheng Xue Bao"},{"issue":"October (46)","key":"10.1016\/j.vaccine.2009.07.015_bib30","doi-asserted-by":"crossref","first-page":"5814","DOI":"10.1016\/j.vaccine.2008.08.031","article-title":"Chimeric hepatitis B virus core particles carrying an epitope of anthrax protective antigen induce protective immunity against Bacillus anthracis","volume":"26","author":"Yin","year":"2008","journal-title":"Vaccine"},{"issue":"December (6)","key":"10.1016\/j.vaccine.2009.07.015_bib31","first-page":"749","article-title":"Expression and characterization of the recombination anthrax lethal factor","volume":"44","author":"Guo","year":"2004","journal-title":"Wei Sheng Wu Xue Bao"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2009.07.015_bib32","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1128\/IAI.64.6.2180-2187.1996","article-title":"Fraction 1 capsular antigen (F1) purification from Yersinia pestis CO92 and from an Escherichia coli recombinant strain and efficacy against lethal plague challenge","volume":"64","author":"Andrews","year":"1996","journal-title":"Infection and Immunity"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2009.07.015_bib33","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1128\/IAI.58.6.1606-1613.1990","article-title":"Production and characterization of monoclonal antibodies against the lethal factor component of Bacillus anthracis lethal toxin","volume":"58","author":"Little","year":"1990","journal-title":"Infection and Immunity"},{"issue":"April (1)","key":"10.1016\/j.vaccine.2009.07.015_bib34","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1365-2249.1999.00859.x","article-title":"An IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse model","volume":"116","author":"Williamson","year":"1999","journal-title":"Clinical and Experimental Immunology"},{"issue":"June (24)","key":"10.1016\/j.vaccine.2009.07.015_bib35","doi-asserted-by":"crossref","first-page":"4747","DOI":"10.1016\/j.vaccine.2007.03.048","article-title":"Evaluation of combinatorial vaccines against anthrax and plague in a murine model","volume":"25","author":"DuBois","year":"2007","journal-title":"Vaccine"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2009.07.015_bib36","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.femsim.2004.10.012","article-title":"Protective efficacy of a recombinant plague vaccine when co-administered with another sub-unit or live attenuated vaccine","volume":"43","author":"Griffin","year":"2005","journal-title":"FEMS Immunology and Medical Microbiology"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2009.07.015_bib37","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1128\/IAI.72.6.3276-3283.2004","article-title":"Enhancement of anthrax lethal toxin cytotoxicity: a subset of monoclonal antibodies against protective antigen increases lethal toxin-mediated killing of murine macrophages","volume":"72","author":"Mohamed","year":"2004","journal-title":"Infection and Immunity"},{"issue":"January (3\u20134)","key":"10.1016\/j.vaccine.2009.07.015_bib38","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.vaccine.2003.07.004","article-title":"Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccine","volume":"22","author":"Little","year":"2004","journal-title":"Vaccine"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2009.07.015_bib39","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1128\/IAI.74.1.794-797.2006","article-title":"Correlation between lethal toxin-neutralizing antibody titers and protection from intranasal challenge with Bacillus anthracis Ames strain spores in mice after transcutaneous immunization with recombinant anthrax protective antigen","volume":"74","author":"Peachman","year":"2006","journal-title":"Infection and Immunity"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2009.07.015_bib40","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1128\/IAI.69.5.2888-2893.2001","article-title":"Search for correlates of protective immunity conferred by anthrax vaccine","volume":"69","author":"Reuveny","year":"2001","journal-title":"Infection and Immunity"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X0901024X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X0901024X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T00:17:47Z","timestamp":1590020267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X0901024X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":40,"journal-issue":{"issue":"52","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S0264410X0901024X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.07.015","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}